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Abstract. – OBJECTIVE: Phosphorylation of 
insulin receptor substrate (IRS) 1 by tumor ne-
crosis factor alpha (TNF-α) has been implicat-
ed as a factor contributing to insulin resistance. 
Administration of IL-15 reduces adipose tissue 
deposition in young rats and stimulates secre-
tion of adiponectin, an insulin sensitizing hor-
mone that inhibits the production and activity 
of TNF-α. We aimed at investigating the effects 
of age life-long moderate calorie restriction (CR) 
on IL-15 and TNF-α signaling in rat white adipose 
tissue (WAT).
MATERIALS AND METHODS: Thirty-six 
8-month-old, 18-month-old, and 29-month-old 
male Fischer344´Brown Norway F1 rats (6 per 
group) were either fed ad libitum (AL) or calorie 
restricted by 40%. The serum levels of IL-15 and 
IL-15 receptor α-chain (IL-15Rα) were increased 
by CR controls regardless of age. An opposite 
pattern was detected in WAT. In addition, CR 
reduced gene expression of TNF-α and cytoso-
lic IRS1 serine phosphorylation in WAT, inde-
pendently from age. 
RESULTS: IL-15 signaling in WAT is increased 
over the course of aging in AL rats compared with 
CR rodents. Protein levels of IL-15Rα are greater 
in WAT of AL than in CR rats independently from 
age. This adaptation was paralleled by increased 
IRS1 phosphorylation through TNF-α-mediated 
insulin resistance. Adiponectin decreased at old 
age in AL rats, while no changes were evident in 
CR rats across age groups.
CONCLUSIONS: IL-15 signaling could there-
fore represent a potential target for interven-
tions to counteract metabolic alterations and the 
deterioration of body composition during aging.
Key Words: 
Adipose tissue, Aging, Calorie restriction, IL-15, IL-15 
receptor, TNF-α, NF-κB, IRS1.
Abbreviations
IRS 1: Insulin Receptor Substrate 1; TNF-α: Tumor 
Necrosis Factor alpha; IL-15: Interleukin-15; WAT: 
White Adipose Tissue; AL: Ad Libitum; CR: Calorie 
Restricted; IL-15R α: IL-15 Receptor α-chain; gc: com-
mon g chain; IL2Rb: IL2 Receptor b chain; F344×BNF1: 
Fischer344×Brown Norway; DEPC: diethylpyrocarbonate; 
PVDF: polyvinylidene difluoride; ANOVA: two-way 
analysis of variance; RW/BW ratio: retroperitoneal ad-
ipose tissue weight/body weight; PPARs: Peroxisome 
proliferator-activated receptors.
Introduction
Obesity is a major public health problem in in-
dustrialized countries, due to its association with 
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a broad range of negative health outcomes (e.g., 
diabetes mellitus and cardiovascular disease)1. 
Insulin resistance is a common feature of obesi-
ty and contributes to obesity-related adverse ef-
fects2. The prevalence of overweight and obesity 
is increasing in older populations3. Furthermore, 
regardless of weight gain, advancing age is ac-
companied by detrimental changes in body com-
position, including reductions in lean body mass 
and relative increases in adiposity, particularly 
visceral fat4.
Adipose tissue fat redistribution occurring 
with age, in turn, is a major risk factor for insulin 
resistance5. Indeed, interventions counteracting 
fat accumulation with age have shown positive 
effects on insulin sensitivity and overall health6-10.
Therapeutic exploitation of IL-15 signaling has 
emerged as a possible strategy against obesity and 
obesity-related health outcomes due to its catabolic 
properties on adipose tissue11. Although IL-15 ex-
pression has not been described in adipose tissue12, 
this cytokine is believed to modulate adipose tis-
sue metabolism, since white adipose tissue (WAT) 
expresses mRNA for all three IL-15 receptor sub-
units: IL-15 receptor α chain (IL-15Rα), common 
g chain (gc), and IL2 receptor b chain (IL2Rb). 
IL-15Rα, is responsible for IL-15 specificity and 
high affinity binding13. The other two subunits are 
shared with IL214. Notably, obese fa/fa rats express 
lower gc levels compared with lean Zucker rats
15. 
In addition, IL-15 administration induced remark-
able reductions in WAT deposition in young rats, 
without affecting food intake11. In support to the 
direct action of IL-15 on fat metabolism, an in vi-
tro study12 showed that exposure to IL-15 inhibited 
lipid accumulation and stimulated secretion of adi-
ponectin by differentiated adipocytes. Adiponectin 
suppresses tumor necrosis factor (TNF)-α mRNA 
expression in endotoxin-treated 3T3-L1 adipo-
cytes16. It is worth mentioning that TNF-α, besides 
its roles in immunomodulatory and inflammato-
ry responses17, may represent a mechanistic link 
between obesity and insulin resistance18. Indeed, 
TNF-α signaling induces a state of insulin resis-
tance by impairing insulin actions at the level of 
the insulin receptor substrate (IRS) proteins. Inter-
estingly, IL-15 stimulates tyrosine phosphorylation 
of IRS-1 in human T cells19. The opposing actions 
of IL-15 and TNF-α on adiponectin and IRS-1 sug-
gest that IL-15 might counteract TNF-α-mediated 
insulin resistance in adipose tissue.
Based on these premises, we investigated the 
effects of aging and life-long moderate calorie 
restriction (CR) on IL-15 expression and the in-
sulin signaling in the rat WAT. We hypothesized 
that advancing age would be associated with 
decreased systemic levels of IL-15 and reduced 
adipose tissue IL-15Rα expression concomi-
tant with lower secretion of adiponectin and in-
creased signaling through the TNF-α-mediated 
pathway of insulin resistance. We further hy-
pothesized that CR would increase the expres-
sion of IL-15 and IL-15Rα along with adiponec-
tin and downregulate TNF-α-mediated IRS1 
serine phosphorylation.
Materials and Methods
Animals
Thirty-six 8-old male, 18-old male, and 29-old 
male Fischer344×Brown Norway (F344×BNF1) 
hybrid rats were purchased from the National In-
stitute on Aging colony at Harlan Industries (In-
dianapolis, IN, USA). The ages were chosen from 
published growth and survival data20 to reflect a 
young age (8 months), adulthood (18 month), and 
advanced age (29 months). In each age group, 
6 animals were fed ad libitum (AL) and 6 were 
calorie restricted by 40%. CR was initiated at 14 
weeks of age at 10% restriction, increased to 25% 
at 15 weeks, and to 40% at 16 weeks. AL rats had 
free access to NIH-31 average nutrient composi-
tion pellets, whereas CR animals received NIH-
31/NIA fortified pellets, once daily, approximate-
ly 1 h before the onset of the dark period. All rats 
had free access to tap water. Rats were individu-
ally housed and maintained on a 12-h light/dark 
cycle, at constant temperature and humidity, in a 
facility approved by the Association for Assess-
ment and Accreditation of Laboratory Animal 
Care at the University of Florida (Gainesville, FL, 
USA). Health status, body weight, and food in-
take were monitored daily. All procedures were in 
compliance with the Guide for the Care and Use 
of Laboratory Animals published by the National 
Institutes of Health and reviewed and approved by 
the University of Florida’s Animal Care and Use 
Committee (USA) before commencement.
Preparation of Cytosolic and Nuclear 
Fractions
Rats were sacrificed by rapid decapitation and 
retroperitoneal, epidydimal and perirenal WAT 
was removed and weighed. Immediately after-
ward, WAT was frozen in liquid nitrogen and 
subsequently stored at -80°C. Experiments were 
conducted on the retroperitoneal WAT portion. 
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Approximately 500 mg of WAT were minced in 
1:1.5 w/v ice-cold lysis buffer (20 mM Tris, 5 mM 
EDTA, 10 mM sodium phosphate, 100 mM so-
dium fluoride, 2 mM sodium orthovanadate, 1% 
NP-40, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 3 
mM benzamidine, 1mM PMSF, pH 7.5), homog-
enized on ice in a glass-glass Duall homogenizer, 
rotated for 1 h at 4°C and centrifuged for 10 min 
at 14,000 × g at 4°C to pellet cellular debris and 
nuclei. The supernatant was collected after re-
moving the top layer of lard-like fat. The resulting 
supernatant, representing the cytosolic fraction, 
was collected, aliquoted, and stored at -80°C for 
later biochemical analyses. Preparation of nuclear 
extracts was performed as previously described21.
Serum Collection 
Trunk blood was collected using a funnel, 
and serum was obtained using plastic Vacutain-
er® 8.5 mL clot activator serum collection tubes 
(#367991, Becton Dickinson; Franklin Lakes, NJ, 
USA). The tubes were inverted (2-3 times) and 
blood was allowed to clot at room temperature for 
1 h, after which the tubes were spun for 10 min 
at 2,000 × g, at 4°C. The serum was eventually 
collected, transferred into 2-mL tubes, and frozen 
at -20°C.
Western Blot Analysis
Prior to loading, samples were boiled at 95°C 
for 5 min in Laemmli buffer (62.5 mM Tris×HCl, 
2% SDS, 25% glycerol, 0.01% bromophenol blue, 
pH 6.8; Bio-Rad, Hercules, CA, USA) with 5% 
b-mercaptoethanol. Proteins were separated using 
5%, 10%, and 15% pre-cast Tris×HCl gels (Bio-
Rad, Hercules, CA, USA). For the quantification 
of TNF-R1, adiponectin, ERK 1, and p-IRS1 ex-
pression, equal volumes of WAT extracts were 
loaded. Nuclear content of NF-κB p65 was deter-
mined by applying 60 µg of protein, whereas 100 
µg were loaded to quantify IL-15 and IL-15Rα in 
serum. Separated proteins were transferred onto 
polyvinylidene difluoride (PVDF) membranes 
(Immobilon P, 0.45 µm, Millipore, Billerica, MA, 
USA) using a semidry blotter (Bio-Rad, Hercu-
les, CA, USA). Transfer efficiency was verified by 
staining the gels with GelCode Blue Stain Reagent 
(Pierce Biotechnology, Rockford, IL, USA) and 
the membranes with Ponceau S (Sigma-Aldrich, 
St. Louis, MO, USA). Ponceau S staining of total 
protein was also used as a loading control. For ad-
iponectin, NF-κB, ERK-1, pIRS-1, IL-15 and IL-
15Rα, nuclear PPARγ experiments, membranes 
were blocked in Starting Block Tris-Buffered Sa-
line (TBS) Blocking Buffer with 0.05% Tween-20 
(Pierce Biotechnology, Waltham, MA, USA) for 
1 h at room temperature, washed in TBS, and in-
cubated overnight at 4°C in rabbit polyclonal an-
ti-adiponectin (Abcam, Cambridge, MA, USA), 
1:200; mouse monoclonal anti-NF-κB p65 (San-
ta Cruz Biotechnology, Santa Cruz, CA, USA), 
1:200; rabbit polyclonal anti-p-ERK1/2( San-
ta Cruz Biotechnology, Santa Cruz, CA, USA), 
1:200; rabbit polyclonal anti-p-IRS-1 (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), 1:200; 
rabbit polyclonal anti-IL-15 (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), 1:200; rabbit poly-
clonal anti-IL-15Rα (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), 1:200. Membranes were 
then washed in TBS with 0.05% Tween-20 (TBS-
tween) and eventually incubated with alkaline 
phosphatase-conjugated secondary anti-rabbit 
(1:30,000; Sigma-Aldrich, St. Louis, MO, USA) 
or mouse (1:30,000; Sigma-Aldrich, St. Louis, 
MO, USA) antibodies, at room temperature for 1 
h. The membranes were washed in TBS-tween, 
rinsed in TBS, and soaked in Tris×HCl (100 mM, 
pH 9.5). Finally, the DuoLux chemiluminescent/
fluorescent substrate for alkaline phosphatase 
(Vector Laboratories, Burlingame, CA, USA) was 
applied, and the chemiluminescent signal was 
captured with an Alpha Innotech Fluorchem SP 
imager (Alpha Innotech, San Leandro, CA, USA). 
Digital images were analyzed using AlphaEase 
FC software (Alpha Innotech, San Leandro, CA, 
USA). Spot density of the target band was nor-
malized to the total lane of Ponceau-stained mem-
brane and expressed in arbitrary optical density 
(OD) units. For the analysis of TNF-R1, the Vec-
tastain ABC-AmP immunodetection kit (Vector 
Laboratories, Segrate, Milan, Italy) was used, 
according to the manufacturer’s instructions. A 
rabbit polyclonal anti-TNF-R1 antibody (Abcam, 
Cambridge, MA, USA) was used at 1:1,000 dilu-
tion. Generation of the chemiluminescent signal, 
digital acquisition, and densitometry analysis 
were performed as described above.
Quantitative Polymerase Chain Reaction 
(qPCR)
To determine the relative gene expression of 
TNF-α, IL-15 Rα, IL2Rα, IL2Rb, gc in WAT, 
Q-PCR analysis was performed. Total RNA was 
isolated using TRI Reagent (Sigma-Aldrich, St. 
Louis, MO, USA). Briefly, ~500 mg of tissues was 
homogenized in 1 mL of TRI Reagent with a mo-
torized mortar and pestle. The homogenate was 
cleared by centrifugation, and RNA isolated from 
IL-15 expression in adipose tissue at old age
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the supernatant according to the manufacturer’s in-
structions. Total RNA was dissolved in diethylpy-
rocarbonate (DEPC)-treated water and quantified 
spectrophotometrically (i.e., 260/280 ratio). To re-
move possible contaminating DNA, DNAse diges-
tion was performed using the TURBO DNAfree 
kit (Ambion, Foster City, CA, USA). First-strand 
cDNA synthesis was achieved from 2 µg of RNA 
using the MasterScript kit (5 Prime, Hamburg, Ger-
many). Briefly, total RNA, 1 µL 0.5 µg oligo d(T) 
primer, 1 µL 50 ng/µL random hexamers, 1 µL 10 
mM dNTP mix and DEPC water were mixed and 
heated to 65°C for 5 min. Samples were then placed 
on ice and 4 µL 25 mM RT-PCR buffer, 1 µL 0.75 
U/µL RT enzyme, 0.5 µL RNAse inhibitor and DE-
PC water added. Samples were subsequently heated 
to 42°C for 1 h and the reaction was terminated by 
heating to 85°C for 5 min. QPCR was performed 
using an Applied Biosystems 7300 Real Time-PCR 
System (ABI, Foster City, CA, USA). TaqMan Uni-
versal PCR Master Mix (2×) (Roche, Branchburg, 
NJ, USA), as well as 0.2 µM primers and TaqMan 
probe mix (ABI) were used for each 25 µL reac-
tion. Amplification of TNF-α (NM_012675), gc 
(NM_080889), IL-2Rα (NM_013163), IL-2Rb 
(NM_013195), IL-15Rα (DQ_157696), and b-actin 
(NM_031144, endogenous control) was achieved 
using predesigned primers and probes (ABI), em-
ploying the following PCR cycling conditions: en-
zyme activation at 95°C for 10 min, 40 cycles of 
denaturation at 95°C for 15 s, anneal/extend at 60°C 
for 1 min. All samples were examined in triplicate, 
with the young AL group used as a calibrator. For 
all genes, negative controls (i.e., no template and no 
reverse transcriptase) were also included and run in 
triplicate. Differences in the expression of the tar-
get genes were explored by the 2-ΔΔCT method22 with 
b-actin as the housekeeping gene.
Statistical Analysis
Statistical analysis was performed using 
GraphPrism 4.0.3 software (GraphPad Software, 
Inc., San Diego, CA, USA). The experiments were 
fully crossed, two-factor designs, with three lev-
els for age (8, 18, and 29 months) and 2 levels for 
diet (AL and CR). The two-way analysis of vari-
ance (ANOVA) allowed distinguishing between 
age and diet effects and a possible interaction ef-
fect between the two factors. In cases where there 
was no interaction effect, we reported whether 
there was a main age effect (independent of di-
et) and/or main diet effect (independent of age). 
When applicable, post-hoc multiple comparisons 
were performed with the Bonferroni’s procedure. 
Pearson’s test was used to explore correlations 
between variables. All tests were two-sided, and 
significance was accepted at p<0.05. All data are 
reported as mean ± SEM.
Results
Morphological Characteristics
Adipose tissue weight 
WAT wet weight increased with advanced 
age (age effect: p<0.0001) (Figure 1a). However, 
changes in adipose tissue weight across ages were 
substantially different in the two diet groups (age 
× diet interaction: p<0.0001) (Figure 1a). In AL 
rats, WAT weight increased significantly only at 
old age (29 months). In contrast, in the CR group, 
WAT weight increased significantly between 8 
and 18 months and remained unchanged thereaf-
ter. As expected, CR animals showed lower WAT 
weight in comparison to their AL counterparts at 
all ages (diet effect: p<0.0001). 
Figure 1. Retroperitoneal adipose tissue absolute wet weight (a), body weight (b) and retroperitoneal adipose tissue weight 
to body weight ratio (MW/BW (c) of 8-month-old, 18-month-old and 29-month-old Fischer344×Brown Norway rats. Letters in-
dicate significant differences (p<0.05) within age groups, and between AL and CR rats of the same age. aSignificantly different 
from 8-mo AL; bsignificantly different from 18-mo AL; csignificantly different from 29-mo AL; dsignificantly different from 
8-mo CR; esignificantly different from 18-mo CR. Values are mean ± SEM (n=6/group).
S. Giovannini, C.S. Carter, C. Leeuwenburgh, A. Flex, F. Biscetti, D. Morgan, A. Laudisio et al 
2742
Body weight 
Within each age group, CR rats weighed less than 
their AL-fed counterparts (diet effect: p<0.0001; 
Figure 1b). However, the trajectory of changes in 
body weight over time was different between diet 
groups (age×diet interaction: p<0.0001). In fact, in 
AL rats, body weight increased progressively from 
8 to 29 months of age (age effect: p<0.0001). In 
contrast, in the CR group body weight remained 
relatively stable over time, with the exception of a 
small increase observed between 18 and 29 months 
of age. Moreover, when WAT weight was normal-
ized to body weight (RW/BW ratio) (Figure 1c), 
AL rats displayed a significantly higher ratio rel-
ative to CR rodents in all age groups (diet effect: 
p<0.0001). Changes in RW/BW with age were 
substantially different in the two diet groups (age 
× diet interaction: p<0.0001). In fact, RW/BW in-
creased between 8 and 18 months in CR rats (age 
effect: p<0.05), while remained unchanged in AL 
animals. 
Expression of IL-15 and IL-15 receptor 
subunits
Because little or no IL-15 mRNA has been 
detected in either undifferentiated pre- or dif-
ferentiated adipocytes12, we measured IL-15 
protein levels in serum to obtain a direct mea-
surement of IL-15. Moreover, since IL-15 ac-
tions are mediated by its interaction with a 
trimeric receptor comprising gc, IL-2Rb, and 
IL-15Rα subunits, their gene expression levels 
were determined in WAT. 
IL-15
The trajectory of changes in serum IL-15 pro-
tein levels across groups showed an age × diet 
interaction (p<0.03) (Figure 2). No significant 
effects of age (p=0.81) or diet (p=0.18) were de-
tected.
IL-15 receptor subunits
In WAT, gene expression of gc and IL-2Rb were 
significantly higher in AL animals compared with 
CR rats (diet effect: p=0.0035 and p=0.0045, re-
spectively) (Figure 3a, b). For the IL-2Rb subunit, 
we also detected an age effect (p=0.0061) and 
Figure 2. Protein levels of IL-15 in serum. In serum, IL-
15 levels vary with advancing age in an opposite manner 
depending on the diet regimen (p <0.03) and are higher in 
CR compared with AL rats. The letters indicate statistical-
ly significant differences (p <0.05) within the groups, and 
between AL and CR rats of the same age. aSignificantly dif-
ferent from 18-month AL. Values  are expressed as averages 
± SE (n = 6 / group).
Figure 3. Relative gene expression of IL-2Rβ (a) and IL2Rγ (b) in adipose tissue. The gene expression of IL-2Rβ and γc is 
significantly lower in CR animals compared to AL rats (p < 0.01). In addition, γc expression shows a progressing decline with 
age (p<0.01) and a significant diet × -age interaction (p<0.05). The letters indicate statistically significant differences (p < 0.05) 
within the groups, and between rats AL and CR of the same age. aSignificantly different from 8-months AL; bsignificantly differ-
ent from 29-months AL. Values are expressed as averages ± SE (n = 6/group).
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an age × diet interaction (p=0.0160) (Figure 3a). 
Indeed, the relative mRNA abundance of IL2Rb 
decreased with advancing age in the AL group, 
which was not evident in CR rats. Likewise, we 
detected a significant higher IL-15Rα gene ex-
pression in AL animals compared with their CR 
counterparts (Figure 4a). 
High affinity α-chain of the IL-15 receptor ex-
ists not only in membrane-anchored but also in 
soluble forms23. Three distinct IL-15Rα soluble 
isoforms have been described24. The two soluble 
IL-15Rα sushi domain isoforms potentiate IL-15 
action25. Conversely, a full-length sIL-15Rα ect-
odomain, released by TNF-α-converting enzyme 
(TACE)-dependent proteolysis, inhibits IL-15 ac-
tivity24. To assess if the increased gene expression 
of IL-15Rα in AL animals was mostly attributable 
to the soluble form of IL-15Rα with inhibitory 
properties, WAT full-length sIL-15Ra protein lev-
els were quantified by Western blot analysis.
sIL-15Ra
Protein levels of sIL-15Rα were significant-
ly higher in WAT from AL animals compared 
with CR rats (diet effect p<0.0001) (Figure 4b). 
However, changes in protein content of sIL-15Rα 
across ages were substantially different in the two 
diet groups (age × diet interaction: p=0.0257). In 
fact, in AL rats, sIL-15Rα increased significantly 
from 8 to 18 months of age (age effect; p=0.0031) 
Figure 4. Adipose tissue gene expression (a) and protein content (b) of IL-15Rα increased in AL fed animals compared to CR 
rats. Letters indicate significant differences (p<0.05) within age groups, and between AL and CR rats of the same age. aSignifi-
cantly different from 8-mo AL; bsignificantly different from 18-mo AL. cSignificantly different from 29-mo AL; dsignificantly 
different from 8-mo CR. Values are mean ± SEM (n=6/group).
Figure 5. Protein levels of adiponectin (a) and nuclear NF-κB in adipose tissue (b). Adiponectin protein levels are significantly 
reduced with age (p = 0.01) and are influenced by the dietary regimen (p<0.01). NF-kB is increased in AL compared with CR rats 
(p <0.01), with different trajectories depending on the diet administered (p <0.001). The letters indicate statistically significant 
differences (p<0.05) within the groups, and between AL and CR rats of the same age. aSignificantly different from 8-month AL; 
bsignificantly different from 18-month AL; csignificantly different from 29-month AL; dsignificantly different from 8-month RC. 
Values  are expressed as averages ± SE (n = 6 / group).
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and remained elevate thereafter. In contrast, no 
significant changes across ages were detected in 
the CR group.
Adipokines
Adiponectin is an anti-inflammatory cytokine26 
that is expressed almost exclusively in adipose tis-
sue27 with significant effects on insulin sensitiv-
ity28-30. Interestingly, IL-15 administration stim-
ulates secretion of adiponectin by differentiated 
3T3-L1 adipocytes12. Thus, adiponectin protein 
levels were determined by Western blot analysis.
Adiponectin
In WAT, changes of adiponectin levels dis-
played a different trajectory over the course 
of aging in AL and CR rats (age × diet interac-
tion: p=0.0029) (Figure 5a). Specifically, in the 
AL group, adiponectin content decreased at 29 
months (age effect: p=0.01), whereas, no changes 
were evident in CR animals across age groups. 
Activation of NF-kB
In aortic endothelial cells adiponectin has 
shown to block TNF-α signaling by preventing 
the activation and translocation of NF-κB31. A 
similar action of adiponectin has been confirmed 
in pig macrophages32 and adipocytes16. In order to 
evaluate the impact of age and CR on NF-κB ac-
tivation, nuclear levels of p65 were determined by 
Western blot analysis.
Nuclear p65
In AL rats, the expression of nuclear p65 in-
creased markedly at 18 months of age compared 
with CR animals, and even further at 29 months 
(diet effect: p=0.0082) (Figure 5b). Converse-
ly, the expression of nuclear p65 remained un-
changed over the course of aging in CR rats (age 
× diet interaction: p=0.0003). No age effect was 
detected (p=0.6205).
In support to the ability of adiponectin to in-
hibit NF-κB activation, a significant negative cor-
relation between adiponectin and NF-κB expres-
sion in WAT was determined (Pearson r: -0.32, p 
<0.05; Figure 6).
PPARs
Peroxisome proliferator-activated receptors 
(PPARs) regulate the expression of several genes 
involved in lipid metabolism and play a key role 
in adipocyte differentiation. Three PPAR iso-
forms have been identified – PPAR-α, PPAR-β, 
PPAR-γ, with the latter being the most abundant 
in WAT where it regulates glucose metabolism. 
In particular, PPARγ activation is able to increase 
WAT adiponectin production33. 
To explore whether delayed reduction of adiponec-
tin in AL rats (29 months) compared with the earlier 
increase of TNF-α (18 month) was linked to high-
er levels of PPAR-γ, the nuclear protein content of 
PPAR-γ was determined. We found that protein lev-
els of nuclear PPAR-γ decreased in the AL group at 
29 months (age effect: p=0.02) (Figure 7). Conversely, 
no changes were evident in CR animals across age 
groups. A previous study reported the opposite34. 
TNF-α-mediated pathway
In vitro studies indicate that TNF-a may con-
tribute to decreased adiponectin production in 
obesity35,36. TNF-α acts on adipose tissue via two 
distinct cell surface receptors termed TNFR1 and 
TNFR2. TNFR1 mediate most of the effects of 
TNF-α on adipose tissue function and is the pre-
dominant receptor for mediating TNF-α-induced 
insulin resistance associated with obesity37,38. To 
evaluate the impact of TNF-α on adipose tissue ad-
iponectin and IRS-1 levels, TNF-α gene expression 
was determined by qPCR, while TNFR1 protein 
levels were measured by Western blot analysis.
TNF-α
In WAT, gene expression of TNF-α was signifi-
cantly higher in AL animals compared with CR 
rats (diet effect: p=0.037) (Figure 8a). No signifi-
cant age effect (p=0.54) or age × diet interaction 
was detected (p=0.56). 
TNF-R1
In WAT, the changes in TNF-R1 levels across 
ages were different in relation to diet (age × diet 
Figure 6. Correlation analysis between adiponectin and 
NF-κb p65. (Pearson’s r: -0.32, p < 0.05). 
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interaction: p=0.0180), resulting in a significant 
increase in TNF-R1 levels in AL animals start-
ing at 18 months (age effect: p=0.0019), with no 
significant changes in CR rats (Figure 8b). We 
detected also a significant diet effect (p=0.0002). 
One of the mechanisms whereby IL-15 impacts 
adipose tissue metabolism might be the inhibition 
of TNF-α. Our data indicate that in AL animals 
the increase of TNF-R1 expression in tissue ad-
ipose occurred at the same age as the elevation 
of IL-15Rα protein. This might suggest a mutual-
ly inhibitory effect between IL-15 and TNF-α in 
adipose tissue. In support to this idea, a positive 
correlation was found between the expression lev-
els of sIL-15Rα and TNF-R1 in WAT (Pearson r: 
0.44, p <0.05; Figure 9).
Phosphorylation of IRS-1 
TNF-α promotes serine/threonine phosphory-
lation of IRS-139. Serine/threonine phosphoryla-
tion of IRS-1 impairs its ability to associate with 
the insulin receptor, which inhibits subsequent 
insulin-stimulated tyrosine phosphorylation40. 
Moreover, TNF-α-induced Ser307phosporylation 
is correlated with the ERK1/2 activation41.
Figure 7. Nuclear levels of PPARγ in 
adipose tissue. In adipocytes, protein 
levels of nuclear PPARγ decreased in 
the AL group in advanced age (age ef-
fect: p=0.02). No changes were evident 
in CR animals across ages.
Figure 8. Relative gene expression of TNFα (a) and protein levels of TNF-R1 (b) in adipose tissue. The TNF-α gene expres-
sion and TNF-R1 protein levels are higher in the AL group than in CR rats (p <0.05 and p <0.001, respectively). Furthermore, 
TNF-R1 levels increase significantly with age (p <0.001) following different trajectories depending on the diet administered (p 
<0.01). The letters indicate statistically significant differences (p <0.05) within the groups, and between AL and CR rats of the 
same age. aSignificantly different from 8-month AL. Values  are expressed as averages ± SE (n = 6 / group).
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p-IRS1
In WAT, the protein content of p-IRS1 was sig-
nificantly greater in AL animals compared with 
CR rats in all age groups (diet effect p<0.0001) 
(Figure 10a). We also detected a significant in-
crease of p-IRS1 in AL animals starting at 18 
months of age (age effect: p=0.02). No significant 
age × diet interaction was detected (p=0.1347).
p-ERK1
Protein expression levels of activated ERK1 
were significantly higher in AL animals relative 
to CR rats (p<0.0001), with a significant age effect 
(p=0.0043) and age × diet interaction (p=0.0437) 
(Figure 10b). Indeed, in AL rats, we detected a 
significant increase in p-ERK1 levels starting at 
18 months of age, while no significant changes 
were evident in CR rats.
p-ERK2
Similar to p-ERK1, the protein content of 
p-ERK2 was significantly higher in AL animals 
compared with CR rats (diet effect p<0.0001) 
(Figure 10c). No significant age effect (p=0.21) or 
age × diet interaction was detected (p=0.30).
Discussion
The interaction between TNF-α and IL-15 sig-
naling in adipose tissue may have significant im-
plications in terms of body composition changes 
with age and metabolic deregulation (e.g., insulin 
resistance, impaired glucose tolerance).
In the present study, changes in serum IL-15 lev-
els during aging were different in relation to diet, 
as evidenced by higher circulating concentrations 
of IL-15 in CR rats (Figure 2). The mRNA abun-
dance of IL-15Rα in WAT was unaffected by age 
in either rat group. Though, gene expression lev-
els of IL-15Rα were lower in WAT from CR rats 
relative to their AL-fed counterpart. This finding 
is in contrast with our original hypothesis that ag-
ing would be associated with reduced levels of IL-
15Rα and that CR would increase the expression 
of IL-15Rα in adipose tissue. To address this unex-
pected finding, we measured WAT protein levels 
of (sIL-15Rα, that possesses inhibitory properties 
on IL1524. Notably, we found a higher expression of 
IL-15Rα inhibitory isoform in AL rats. This may 
lead to hypothesize that the higher gene expression 
of IL-15Rα detected in AL rats might be mostly 
accounted for the inhibitor isoform of IL-15Rα. 
One mechanism by which IL-15 exerts positive 
effects both in vitro42 and in vivo43 is by blocking 
TNF-α signaling. In particular, IL-15 adminis-
tration to cachectic rats resulted in decreased ex-
pression of both TNF-α receptors (TNF-R1 and 
TNF-R2) in skeletal muscle43. In our study, CR 
was associated with decreased TNF-R1 protein 
levels in WAT, while in AL animals, TNF-R1 ex-
pression increased starting at 18 months of age. 
To further support this finding, we observed a 
positive correlation between WAT content of 
inhibitory sIL-15Rα and TNF-R1 protein levels 
(Pearson’s r: 0.44, p=0.006; Figure 9).
Consistent with changes in TNF-R1 expres-
sion, AL rats showed increased activation of 
ERK-1 and consequent phosphorylation of insulin 
receptor 1 (Figure 10). According to our original 
hypothesis and the protective role postulated for 
dietary restriction, CR animals did not show al-
terations in the expression of TNF-α receptor or 
phosphorylation of insulin receptor 1. Further-
more, in WAT, the protein content of p-IRS1 was 
higher in AL animals with a significant increase 
starting at 18 months of age. 
Adiponectin is a major modulator of systemic 
insulin sensitivity and glucose metabolism. We 
showed that adiponectin decreased in AL animals 
only at old age, while in the CR group its expres-
sion remains unvaried across ages. According to 
reports from other groups16,31,32, we found an in-
crease in nuclear translocation of p65 in AL rats 
temporally coinciding with adiponectin reduction 
(Figure 5). On the other hand, CR resulted in a 
significant reduction in p65 levels in old rats (29 
months), suggesting that this dietary regimen, 
even at old age, plays a protective role on media-
tors of inflammation such as NF-κB. In support to 
the ability of adiponectin to inhibit NF-κB activa-
tion, we found a negative correlation between ad-
iponectin and WAT NF-κB expression (Pearson r: 
-0.32, p <0.05; Figure 6).
Figure 9. Correlation analysis between sIL-15Rα and 
TNF-R1 (Pearson r: 0.44, p < 0.05)
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However, the lack of temporal agreement among 
changes in TNF-R1 expression, adiponectin levels, 
and nuclear NF-κB p65 content suggests the exis-
tence of a compensatory mechanism to maintain 
insulin sensitivity in the presence of TNF-R1activa-
tion. This mechanism could involve the conserved 
expression of PPARγ during adulthood (18 months), 
since an age-related reduction of nuclear levels of 
these receptors has been reported44. In fact, the pres-
ervation of PPARγ receptor expression and their ac-
tivation by specific ligands (e.g., thiazolidinediones) 
promote an increased secretion of adiponectin33, by 
inhibiting the action of TNF-α on a specific promot-
er region of adiponectin45. Along with this finding, 
we showed that, in WAT, the protein levels of nucle-
ar PPARγ decreased only in old AL rats. 
Conclusions
Our findings indicate that AL-fed rats show 
higher expression of sIL-5Rα. In keeping with 
the upregulation of sIL-15Rα, TNF-α-mediated 
insulin-resistance signaling may occur in AL 
rats. CR, irrespective of age, is associated with 
reduced expression of sIL-15Rα and reduced acti-
vation of TNF-α signaling. IL-15 signaling could 
therefore represent a potential target for interven-
tions to counteract metabolic alterations and the 
deterioration of body composition during aging.
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